The STEM-PD research team will now continue the long-term follow-up of the participants to further evaluate safety, graft function, and clinical benefit.
Kenai Therapeutics, a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions, today announced the completion of enrollment for the REPLACEtm Phase ...
Latest findings on neflamapimod to be featured in presentations demonstrating its impact on dementia with Lewy bodies (DLB) disease progression, ...
PsyPost on MSN
Neuroscience breakthrough uses AI to uncover the cellular building blocks of human speech
A study recently published in the journal Nature provides evidence that individual brain cells in the human cortex act as ...
Inherited retinal degenerations are a diverse group of genetic disorders that result in progressive vision loss. Advances in ...
A landmark study led from Lund, Sweden, has shown that transplanting stem-cell derived dopamine progenitor cells into the ...
Lund University. In Parkinson’s disease, patients lose nerve cells in the brain that produce dopamine which leads to symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results